Healthcare -
Biotechnology - NASDAQ - US
$ 2.46
-0.806 %
$ 85 M
Market Cap
-2.62
P/E
GNLX - INTEREST INCOME & EXPENSE
Interest Income & Expense GNLX - Genelux Corporation
3.97 M
LAST VALUE
67.47%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR